Related Experiment Video

Updated: Jul 17, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

Identification of XAF1 as an antagonist of XIAP anti-Caspase activity

P Liston1, W G Fong, N L Kelly

  • 1Cancer Research Group, Ottawa Regional Cancer Center, 501 Smyth Road, Ottawa, K1H 8L6, Canada.

Nature Cell Biology
|February 15, 2001
PubMed

Insights

XIAP-associated factor 1 (XAF1) antagonizes XIAP, a protein that suppresses apoptosis. Low XAF1 levels in cancer cells may contribute to apoptosis resistance, suggesting XAF1’s role in cancer development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Inhibitors of apoptosis (IAPs) are critical regulators of programmed cell death by inhibiting the caspase cascade.
  • Dysregulation of apoptosis is a hallmark of cancer, contributing to tumor development and resistance to therapy.

Purpose of the Study:

  • To identify and characterize novel proteins that interact with XIAP, a key member of the IAP family.
  • To investigate the role of XIAP-associated factor 1 (XAF1) in regulating XIAP activity and its potential involvement in cancer.

Main Methods:

  • Protein isolation based on binding affinity to XIAP.
  • In vitro assays to assess XIAP and XAF1 activities.
  • Cellular localization studies of XIAP in response to XAF1 expression.
  • Analysis of XAF1 expression levels in normal tissues and cancer cell lines.

Main Results:

  • XIAP-associated factor 1 (XAF1) was identified as a binding partner of XIAP.
  • XAF1 antagonizes XIAP's ability to suppress caspase activation and cell death.
  • XAF1 expression induces the nuclear translocation of XIAP.
  • XAF1 is widely expressed in normal tissues but significantly downregulated in many cancer cell lines.

Conclusions:

  • XAF1 functions as a negative regulator of XIAP, promoting apoptosis.
  • The reduced expression of XAF1 in cancer cells may contribute to their resistance to apoptosis.
  • XAF1 represents a potential therapeutic target or biomarker for cancer treatment.

More Related Videos

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection08:16

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection

Published on: July 21, 2022

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry05:29

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry

Published on: March 24, 2023

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...